Leukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 1,500/mcLXx_NEWLINE_xXLeukocytes >= 2,500/mcL, within 2 weeks of randomizationXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXWithin 14 days of treatment initiation: Leukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/ mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXWithin less than or equal to 14 days prior to registration: Leukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcL within 4 weeks before randomizationXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXleukocytes ?3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes ? 3,000/mcL within 14 days of registrationXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes ? 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcL (>= 3,000/mm^3)Xx_NEWLINE_xXLeukocytes >= 2,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3.0 x 10^9/LXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXENDOCRINE RESISTANT AND ADJUVANT COHORT: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes ? 3,000/mcLXx_NEWLINE_xXObtained within 21 days prior to study registration: leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 1,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mclXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 2,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXWithin 2 weeks prior to initiation of study treatment: Leukocytes >= 3,000/mcLXx_NEWLINE_xXCOHORT I: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3 x 10^9/LXx_NEWLINE_xXLeukocytes ? 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL.Xx_NEWLINE_xXLeukocytes >= 3,000/mcL, =< 5 days prior to cycle 1 (C1) day 1 (D1)Xx_NEWLINE_xXLeukocytes >= 3,000/mcL.Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL.Xx_NEWLINE_xXLeukocytes <3.0 x 109/LXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mm^3Xx_NEWLINE_xXLeukocytes ? 3,000/uLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uL.Xx_NEWLINE_xXLeukocytes >= 3,000/mcL within 14 days of treatment initiationXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXObtained within 21 days of registration: leukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL 14 days or fewer from registrationXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL (without growth factor)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 1500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3 x 10^9/LXx_NEWLINE_xXLeukocytes >= 1500/mcL, within 14 days prior to treatmentXx_NEWLINE_xXLeukocytes >= 3000 mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXPHASE II: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXWithin 14 days prior to registration: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcL, obtained within 14 days of first dose of drugXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXPHASE I: Leukocytes >= 3,000/mcLXx_NEWLINE_xXPHASE II SCLC: Leukocytes >= 3,000/mcLXx_NEWLINE_xXUROTHELIAL CARCINOMA EXPANSION COHORT: Leukocytes >= 3,000/mcLXx_NEWLINE_xXmCRPC EXPANSION COHORT: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000 cells/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes: >= 3,000/mcl (lymphocyte [lymph] %: >= 10%)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uL obtained within 14 days of first treatmentXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes < 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000 cells/uL (to be performed within 7 days prior to start of study treatment)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/ulXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 1,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/µLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/uL (within 2 weeks prior to radiotherapy)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mLXx_NEWLINE_xXWithin 4 weeks of preregistration: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >3,000/mcLXx_NEWLINE_xXLeukocytes ? 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 1,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000 per mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mm^3, obtained =< 7 days prior to registrationXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 1,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXDOSE ESCALATION COHORT: Leukocytes ? 3,000/mcLXx_NEWLINE_xXDOSE EXPANSION COHORT: Leukocytes ? 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXMeasured within 28 days prior to administration of study treatment: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXSecondary Registration: leukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,500/mcLXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXWithin 14 days of registration: Leukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXPHASE II: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXPHASE II: Leukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL; these results must be obtained within 28 days prior to registrationXx_NEWLINE_xXLeukocytes no lower limitXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 4,000/ulXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000 per mm^3Xx_NEWLINE_xXObtained within 30 days of registration: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL, within 14 days of study registrationXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3.0 x 10^9/LXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/?LXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcL (labs should be performed within 14 days of treatment initiation)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes greater than 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mLXx_NEWLINE_xXLeukocytes >= 3,000/microLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXPHASE I: Leukocytes >= 3,000/mcLXx_NEWLINE_xXPHASE II: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXPART B: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXREGISTRATION INCLUSION CRITERIA: Leukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes ? 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes ? 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 2,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >3,000/mm3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes: >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes > 1,500/mcLXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes: >= 3,000/ulXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,00/mcLXx_NEWLINE_xXPerformed within 10 days of treatment initiation: Leukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/microliter (mcL)Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 2,500/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3 K/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 2,000/mcLXx_NEWLINE_xXLeukocytes >= 3000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes: >= 3,000/mm^3Xx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 2,500/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 2,500/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/microliterXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcL (within 14 days of study registration)Xx_NEWLINE_xXLeukocytes > 3,000/uLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mLXx_NEWLINE_xXLeukocytes >= 3,000 /uLXx_NEWLINE_xXLeukocytes ? 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes > 3,000/mcLXx_NEWLINE_xXLeukocytes >= 3,000/mcLXx_NEWLINE_xX